サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1710151

臨床研究機関の世界市場レポート 2025年

Clinical Research Organization Global Market Report 2025

出版日
ページ情報
英文 200 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
臨床研究機関の世界市場レポート 2025年
出版日: 2025年04月03日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

臨床研究機関市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.7％で946億1,000万米ドルに成長します。予測期間の成長は、個別化医療へのシフト、臨床試験の増加、医薬品開発パイプラインの増加、医薬品研究開発費、バイオ医薬品の成長に起因します。予測期間における主な動向としては、臨床試験における人工知能（AI）、戦略的パートナーシップと提携、技術的進歩、クラウドベースの臨床試験プラットフォーム、製品の革新などが挙げられます。

個別化医療に対する需要の高まりは、臨床研究機関（CRO）市場の拡大を促進すると予測されます。個別化医療は、精密医療や個別化医療とも呼ばれ、各患者の特性に合わせた治療や介入に焦点を当てています。この需要の急増は、ゲノミクスとバイオテクノロジーの進歩によるところが大きく、個々の遺伝子プロファイルや健康状態に基づき、より的を絞った効果的な治療が可能になります。CROは、個々の遺伝子や生物学的プロファイルに応じて治療をカスタマイズするための専門的な試験や分析を実施することで、個別化医療において重要な役割を果たしています。例えば、2024年2月、米国の非営利団体である個別化医療連合（Personalized Medicine Coalition）は、FDAが希少疾患の新規個別化治療を2022年の6件から2023年には16件承認したと報告しました。このような個別化医療に対する需要の高まりが、CRO市場の成長を後押ししています。

CRO市場の主なプレイヤーは、データ統合、分析、試験効率を改善するために、人工知能主導のエンドツーエンド・データ・プラットフォームなどの先進的なソリューションを開発しています。これらのプラットフォームは、データの収集から実用的な洞察に至るまで、データのライフサイクル全体を通じてAIを使用してデータを管理、分析、最適化します。例えば、米国のCROであるElligo Health Research Inc.は2023年1月、データ駆動型臨床研究を加速するために設計された革新的なデータ・技術プラットフォームであるDataAI Connectを発表しました。このプラットフォームは、実際の患者データの収集、管理、分析、共有を統合し、単なる補助技術としてではなく、臨床試験の課題に対処する包括的なソリューションを提供します。この汎用性の高いプラットフォームは、医療記録の検索と分析にオールインワンのアプローチを提供します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界臨床研究機関PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界の臨床研究機関市場：成長率分析
  • 世界の臨床研究機関市場の実績：規模と成長, 2019-2024
  • 世界の臨床研究機関市場の予測：規模と成長, 2024-2029, 2034F
  • 世界臨床研究機関総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の臨床研究機関市場：サービス別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 創薬サービス
  • 前臨床サービス
  • 臨床サービス
  • 承認後サービス
  • 世界の臨床研究機関市場生産別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 社内
  • アウトソーシング
  • 世界の臨床研究機関市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 腫瘍学
  • 中枢神経系
  • 心血管疾患
  • 代謝障害
  • 免疫学
  • 呼吸器
  • 筋骨格系障害
  • 血液疾患
  • 世界の臨床研究機関市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 製薬およびバイオテクノロジー企業
  • 医療機器企業
  • 政府と民間企業
  • 学術機関
  • その他のエンドユーザー
  • 世界の臨床研究機関市場創薬サービスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ターゲットの識別と検証
  • リード最適化
  • 前臨床開発
  • バイオマーカーの発見
  • 世界の臨床研究機関市場前臨床サービスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 毒性学研究
  • 薬物動態学と薬力学
  • 動物モデル研究
  • GLP（優良試験所基準）研究
  • 世界の臨床研究機関市場、臨床サービスのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • フェーズI試験
  • フェーズII試験
  • フェーズIII試験
  • 臨床試験管理
  • 規制関連業務
  • 世界の臨床研究機関市場、承認後サービスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • フェーズIV試験
  • 市販後調査
  • 安全監視と報告
  • 市場アクセスと医療経済サービス

第7章 地域別・国別分析

  • 世界の臨床研究機関市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の臨床研究機関市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 臨床研究機関市場：競合情勢
  • 臨床研究機関市場：企業プロファイル
    • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • PPD Inc. Overview, Products and Services, Strategy and Financial Analysis
    • ICON plc Overview, Products and Services, Strategy and Financial Analysis
    • Syneos Health Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Charles River Laboratories International Inc.
  • Parexel International Corporation
  • Medpace Holdings Inc.
  • Almac Group Ltd
  • Premier Research Group Limited
  • Novotech Health Holdings Pty Ltd
  • Clario
  • Caidya Inc.
  • Altasciences
  • Ergomed plc
  • Emmes Group of Companies Inc.
  • Richmond Pharmacology Ltd
  • LINK Medical Research
  • Nuventra Pharma Sciences Inc.
  • Medlab Clinical Ltd

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 臨床研究機関市場2029：新たな機会を提供する国
  • 臨床研究機関市場2029：新たな機会を提供するセグメント
  • 臨床研究機関市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r31730

Clinical research organizations (CROs) are specialized service providers that oversee and execute clinical trials for companies in the pharmaceutical, biotechnology, and medical device sectors. They manage various facets of research, such as designing studies, handling data, and ensuring regulatory compliance, thereby facilitating the drug development process and maintaining adherence to regulatory requirements.

CROs offer several key services, including drug discovery, pre-clinical services, clinical services, and post-approval services. Drug discovery involves a series of processes and technologies aimed at identifying and developing new pharmaceutical compounds, from initial research to preclinical testing. These services can be performed in-house or outsourced and cover a wide range of conditions such as oncology, central nervous system disorders, cardiovascular diseases, metabolic disorders, immunology, respiratory issues, musculoskeletal disorders, and hematological disorders. They are used by various entities, including pharmaceutical and biotechnology companies, medical device manufacturers, governments, private firms, academic institutions, and more.

The clinical research organization market research report is one of a series of new reports from The Business Research Company that provides clinical research organization market statistics, including the clinical research organization industry's global market size, regional shares, competitors with a clinical research organization market share, detailed clinical research organization market segments, market trends and opportunities, and any further data you may need to thrive in the clinical research organization industry. This clinical research organization market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The clinical research organization market size has grown strongly in recent years. It will grow from $59.41 $ billion in 2024 to $65.34 $ billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to an aging population, rise in chronic conditions, globalization of clinical trials, growing focus on orphan drug development, and government funding and grants.

The clinical research organization market size is expected to see strong growth in the next few years. It will grow to $94.61 $ billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to a shift towards personalized medicine, an increase in clinical trials, increased drug development pipelines, pharmaceutical research and development spending, and biopharmaceutical growth. Major trends in the forecast period include artificial intelligence (AI) in clinical trials, strategic partnerships and collaborations, technological advancements, cloud-based clinical trial platforms, and product innovation.

The growing demand for personalized medicine is projected to drive the expansion of the clinical research organization (CRO) market. Personalized medicine, also known as precision or individualized medicine, focuses on tailoring treatments and interventions to the specific characteristics of each patient. This surge in demand is largely due to advancements in genomics and biotechnology, which allow for more targeted and effective treatments based on individual genetic profiles and health conditions. CROs play a crucial role in personalized medicine by conducting specialized trials and analyses to customize treatments according to individual genetic and biological profiles. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit, reported that the FDA approved 16 novel personalized therapies for rare diseases in 2023, up from six in 2022. This rising demand for personalized medicine is driving the growth of the CRO market.

Key players in the CRO market are developing advanced solutions, such as artificial intelligence-driven end-to-end data platforms, to improve data integration, analysis, and trial efficiency. These platforms use AI to manage, analyze, and optimize data throughout its entire lifecycle, from collection to actionable insights. For example, in January 2023, Elligo Health Research Inc., a US-based CRO, launched DataAI Connect, an innovative data and technology platform designed to accelerate data-driven clinical research. The platform integrates data collection, management, analysis, and sharing of real-world patient data, offering a comprehensive solution to address clinical trial challenges rather than merely serving as an adjunct technology. This versatile platform provides an all-in-one approach for retrieving and analyzing medical records.

In March 2024, Veeda Clinical Research Ltd., an India-based CRO, acquired Heads for an undisclosed amount. This acquisition enables Veeda to broaden its contract research services from discovery through clinical development and post-commercial launch, offering a full range of CRO services across early to late-phase trials. Heads, based in Ireland, specializes in clinical research and drug development consulting.

Major companies operating in the clinical research organization market are Laboratory Corporation of America Holdings, IQVIA Holdings Inc., PPD Inc., ICON plc, Syneos Health Inc., Charles River Laboratories International Inc., Parexel International Corporation, Medpace Holdings Inc., Almac Group Ltd, Premier Research Group Limited, Novotech Health Holdings Pty Ltd, Clario, Caidya Inc., Altasciences, Ergomed plc, Emmes Group of Companies Inc., Richmond Pharmacology Ltd, LINK Medical Research, Nuventra Pharma Sciences Inc., Medlab Clinical Ltd.

North America was the largest region in the clinical research organization market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical research organization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the clinical research organization market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clinical research organization market includes revenues earned by entities by providing services such as clinical trial management, data management and biostatistics, medical writing, pharmacovigilance, patient recruitment and retention, clinical monitoring, and quality assurance and compliance. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Research Organization Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical research organization market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for clinical research organization ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical research organization market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Service: Drug Discovery Services; Pre-Clinical Services; Clinical Services; Post Approval Services
  • 2) By Production: In-house; Outsourced
  • 3) By Indication: Oncology; Central Nervous System; Cardiovascular Diseases; Metabolic Disorders; Immunology; Respiratory; Musculoskeletal Disorders; Hematological Disorders
  • 4) By End User: Pharmaceutical And Biotechnology Companies; Medical Device Companies; Governments And Private Firms; Academic Institutions; Other End Users
  • Subsegments:
  • 1) By Drug Discovery Services: Target Identification and Validation; Lead Optimization; Preclinical Development; Biomarker Discovery
  • 2) By Pre-Clinical Services: Toxicology Studies; Pharmacokinetics and Pharmacodynamics; Animal Model Studies; GLP (Good Laboratory Practice) Studies
  • 3) By Clinical Services: Phase I Trials; Phase II Trials; Phase III Trials; Clinical Trial Management; Regulatory Affairs
  • 4) By Post Approval Services: Phase IV Studies; Post-Market Surveillance; Safety Monitoring and Reporting; Market Access and Health Economics Services
  • Companies Mentioned: Laboratory Corporation of America Holdings; IQVIA Holdings Inc.; PPD Inc.; ICON plc; Syneos Health Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Clinical Research Organization Market Characteristics

3. Clinical Research Organization Market Trends And Strategies

4. Clinical Research Organization Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Clinical Research Organization Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Clinical Research Organization PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Clinical Research Organization Market Growth Rate Analysis
  • 5.4. Global Clinical Research Organization Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Clinical Research Organization Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Clinical Research Organization Total Addressable Market (TAM)

6. Clinical Research Organization Market Segmentation

  • 6.1. Global Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Discovery Services
  • Pre-Clinical Services
  • Clinical Services
  • Post Approval Services
  • 6.2. Global Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • In-house
  • Outsourced
  • 6.3. Global Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Central Nervous System
  • Cardiovascular Diseases
  • Metabolic Disorders
  • Immunology
  • Respiratory
  • Musculoskeletal Disorders
  • Hematological Disorders
  • 6.4. Global Clinical Research Organization Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Medical Device Companies
  • Governments And Private Firms
  • Academic Institutions
  • Other End Users
  • 6.5. Global Clinical Research Organization Market, Sub-Segmentation Of Drug Discovery Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Target Identification and Validation
  • Lead Optimization
  • Preclinical Development
  • Biomarker Discovery
  • 6.6. Global Clinical Research Organization Market, Sub-Segmentation Of Pre-Clinical Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Toxicology Studies
  • Pharmacokinetics and Pharmacodynamics
  • Animal Model Studies
  • GLP (Good Laboratory Practice) Studies
  • 6.7. Global Clinical Research Organization Market, Sub-Segmentation Of Clinical Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Phase I Trials
  • Phase II Trials
  • Phase III Trials
  • Clinical Trial Management
  • Regulatory Affairs
  • 6.8. Global Clinical Research Organization Market, Sub-Segmentation Of Post Approval Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Phase IV Studies
  • Post-Market Surveillance
  • Safety Monitoring and Reporting
  • Market Access and Health Economics Services

7. Clinical Research Organization Market Regional And Country Analysis

  • 7.1. Global Clinical Research Organization Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Clinical Research Organization Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Clinical Research Organization Market

  • 8.1. Asia-Pacific Clinical Research Organization Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Clinical Research Organization Market

  • 9.1. China Clinical Research Organization Market Overview
  • 9.2. China Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Clinical Research Organization Market

  • 10.1. India Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Clinical Research Organization Market

  • 11.1. Japan Clinical Research Organization Market Overview
  • 11.2. Japan Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Clinical Research Organization Market

  • 12.1. Australia Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Clinical Research Organization Market

  • 13.1. Indonesia Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Clinical Research Organization Market

  • 14.1. South Korea Clinical Research Organization Market Overview
  • 14.2. South Korea Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Clinical Research Organization Market

  • 15.1. Western Europe Clinical Research Organization Market Overview
  • 15.2. Western Europe Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Clinical Research Organization Market

  • 16.1. UK Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Clinical Research Organization Market

  • 17.1. Germany Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Clinical Research Organization Market

  • 18.1. France Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Clinical Research Organization Market

  • 19.1. Italy Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Clinical Research Organization Market

  • 20.1. Spain Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Clinical Research Organization Market

  • 21.1. Eastern Europe Clinical Research Organization Market Overview
  • 21.2. Eastern Europe Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Clinical Research Organization Market

  • 22.1. Russia Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Clinical Research Organization Market

  • 23.1. North America Clinical Research Organization Market Overview
  • 23.2. North America Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Clinical Research Organization Market

  • 24.1. USA Clinical Research Organization Market Overview
  • 24.2. USA Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Clinical Research Organization Market

  • 25.1. Canada Clinical Research Organization Market Overview
  • 25.2. Canada Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Clinical Research Organization Market

  • 26.1. South America Clinical Research Organization Market Overview
  • 26.2. South America Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Clinical Research Organization Market

  • 27.1. Brazil Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Clinical Research Organization Market

  • 28.1. Middle East Clinical Research Organization Market Overview
  • 28.2. Middle East Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Clinical Research Organization Market

  • 29.1. Africa Clinical Research Organization Market Overview
  • 29.2. Africa Clinical Research Organization Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Clinical Research Organization Market, Segmentation By Production, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Clinical Research Organization Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Clinical Research Organization Market Competitive Landscape And Company Profiles

  • 30.1. Clinical Research Organization Market Competitive Landscape
  • 30.2. Clinical Research Organization Market Company Profiles
    • 30.2.1. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. PPD Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. ICON plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Syneos Health Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Clinical Research Organization Market Other Major And Innovative Companies

  • 31.1. Charles River Laboratories International Inc.
  • 31.2. Parexel International Corporation
  • 31.3. Medpace Holdings Inc.
  • 31.4. Almac Group Ltd
  • 31.5. Premier Research Group Limited
  • 31.6. Novotech Health Holdings Pty Ltd
  • 31.7. Clario
  • 31.8. Caidya Inc.
  • 31.9. Altasciences
  • 31.10. Ergomed plc
  • 31.11. Emmes Group of Companies Inc.
  • 31.12. Richmond Pharmacology Ltd
  • 31.13. LINK Medical Research
  • 31.14. Nuventra Pharma Sciences Inc.
  • 31.15. Medlab Clinical Ltd

32. Global Clinical Research Organization Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Clinical Research Organization Market

34. Recent Developments In The Clinical Research Organization Market

35. Clinical Research Organization Market High Potential Countries, Segments and Strategies

  • 35.1 Clinical Research Organization Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Clinical Research Organization Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Clinical Research Organization Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer